From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

The Islamabad High Court (IHC) has rejected a petition that sought to delay the upcoming Central Superior Services (CSS) 2025 ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

The appointment of seven Supreme Court judges under Chief Justice of Pakistan (CJP) Yahya Afridi has sparked concerns that ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration with OnTargetx R&D Inc. to ...

The Federal Public Service Commission (FPSC) has officially confirmed that the Central Superior Services (CSS) 2025 examination will proceed as planned, beginning tomorrow (Saturday, 5, 2025).

GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Scot Niglio discussing two abstracts: “Safety and efficacy of neoadjuvant immunotherapy with ...

Oxytocin receptor (Oxtr) signaling influences complex social behaviors in diverse species, including social monogamy in prairie voles. How Oxtr regulates specific components of social attachment ...

Surf Abu Dhabi Pro, which runs from February 14-16, is bringing elite surfing to the region while significantly boosting the local touri ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...